CTS (CTS) Investor presentation summary

Business profile and financial snapshot

• LTM revenue was $571 million through September 2026; adjusted EBITDA margin was 24%, and adjusted diluted EPS was $2.75.

• LTM revenue mix: transportation 41%, industrial 27%, medical 18%, and aerospace and defense 14%; diversified markets represented 59%.

• Global design and manufacturing footprint spans North America (57% of revenue), Europe (23%), and Asia (20%); more than 90% of revenue is custom engineered.

Growth strategy and market opportunities

• Diversified-market revenue increased from 35% in 2017 to 59% LTM; the long-term diversified-market growth target is 10% CAGR.

• Industrial LTM revenue was $153 million, up 13% YoY, against a $3.6 billion addressable market and mid-single-digit estimated market growth.

• Medical LTM revenue was $103 million, up 33% YoY, against a $1.5 billion addressable market and mid-single-digit estimated market growth.

• Aerospace and defense LTM revenue was $80 million, down 7% YoY; transportation LTM revenue was $235 million, flat YoY.

• Secular demand drivers include healthcare innovation, defense spending, industrial automation and digitalization, and energy efficiency.

Portfolio and acquisition

• Core capabilities include advanced ceramics, magnetics, piezoelectric ceramics, acoustic sensing, temperature and position sensing, and signal processing.

• The Millar acquisition adds MEMS pressure, pH, and conductivity sensing for medical, life sciences, and industrial applications; expected annual revenue is ~$30 million, with accretion expected in 2H 2027.

• Acquisition strategy targets product extensions, value-added products, and adjacent markets; more than $450 million has been deployed on acquisitions since 2016.